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Abstract
Women with lupus are at increased risk for developing cardiovascular disease 
(CVD). Previous studies of atherosclerosis in SLE have not been representa-
tive of the minority groups most affected by lupus and its complications. 
Therefore, a study of 41 lupus cases and 83 controls was conducted to 
investigate the relationship between carotid atherosclerosis and inflamma-
tion in African-American women.  Participation consisted of a questionnaire, 
physical examination, fasting blood draw, and ultrasound of the carotid 
arteries. There were observed differences between cases and controls with 
regard to carotid intima media thickness (IMT) and traditional cardiovascular 
risk factors, although few reached statistical significance. Tumor Necrosis 
Factor-alpha was significantly related to carotid IMT, lupus, body mass index, 
and hypertension, indicating that it may be an important factor to consider 
in future studies of cardiovascular risk in African American women with lu-
pus.  This study adds to scientific literature by demonstrating that there may 
be other factors in the link between SLE and CVD.  
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INTRODUCTION
In the United States, Systemic Lupus Erythematosus (SLE) dispropor-
tionately affects African American women.  African Americans in the United 
States have three-fold higher incidence and prevalence rates of SLE, as well 
as cause-specific mortality rates, compared with Whites (Alarcon et al., 2005; 
Oates et al., 2003; Rus & Hochberg, 2002).  Additionally, young women are 
most frequently affected by the disease, outnumbering male patients ten to 
one (Cooper, Dooley, Treadwell, St Clair, & Gilkeson, 2002).
A leading cause of death for persons with lupus is cardiovascular dis-
ease (CVD) (Office of Minority Health, 2004; Rus & Hochberg, 2002).  Studies 
have shown that women with lupus are 5 to 8 times more likely to develop 
coronary heart disease (CHD) than women in the general population (Manzi, 
Meilahn, Rairie, & al, 1997; Petri, Perez-Gutthann, Spence, & al, 1992).  Major 
cardiovascular risk factors for the general population (i.e., smoking, hyperten-
sion, obesity, sedentary lifestyle, and dyslipidemia) are also observed in SLE 
(Ho et al., 2005; Toloza et al., 2004).  Very little is known about the risk factors 
in African Americans with SLE, although there is data to suggest that they may 
not be identical to those seen in Caucasian populations (Adeniyi et al., 2002; 
Henderson, Bretsky, Henderson, & Stram, 2001), indicating the critical nature 
of a study that explores the risk factors of CVD in African Americans with SLE.  
The mechanism of the increased CVD rate in SLE is not well understood.  
Overall, literature indicates that SLE patients have multiple CVD risk factors 
present more often than individuals in the general population (Doria et al., 
2003; Manzi & Wasko, 2000; Ramsey-Goldman & Manzi, 2001; Svenungsson 
et al., 2001; Van Doornum, McColl, & Wicks, 2002; Vlachoyiannopoulos et al., 
2003).  However, some studies that have used the Framingham risk factor 
assessment in SLE patients and controls, have shown that the 10-year risk of a 
CHD-related event is the same in patients and controls, indicating that other 
factors are contributing to the increased CVD rate in SLE (Bruce, Urowitz, & al, 
2003; Chung, Oeser, Avalos, Raggi, & Stein, 2006; Manzi et al., 1997; Petri et al., 
1992).  In non-lupus patients, there is an association between inflammation 
markers and CVD (Kuller, Tracy, Shaten, Meilahn, & Group, 1996).  This raises 
the possibility that the severe systemic inflammation seen in SLE may bring 
about high CVD mortality by causing accelerated atherosclerosis (Manzi & 
Wasko, 2000; Van Doornum et al., 2002).  While it has been suggested that 
non-traditional mechanisms outside of traditional cardiovascular risk factors 
may modulate some of the increased risk for heart disease and increase in 
carotid IMT associated with lupus in women, this trend has not been explored 
specifically in African American women.
While many studies have focused on clinically overt heart disease as a 
cardiovascular endpoint, an emerging trend has been the use of ultrasound to 
study thickening of the interior lining of the arteries or intima media thick-
ness (IMT) as a measure of subclinical atherosclerosis.  The carotid arteries are 
easily accessible to noninvasive study using ultrasound techniques, and these 
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techniques provide accurate and reliable measurement of atherosclerosis in 
its subclinical stages (Espeland et al., 1996; Li et al., 1996; Persson, Formgren, 
Israelsson, & Berglund, 1994; Sutton-Tyrrell, Wolfson, Thompson, & Kelsey, 
1992).  However, few studies have used ultrasound to measure subclinical 
atherosclerosis in women with SLE (Manzi & Wasko, 2000; Ramsey-Goldman 
& Manzi, 2001; Van Doornum et al., 2002; Vlachoyiannopoulos et al., 2003; 
Wolak, Todosoui, & al, 2004).  In those that have, the majority observed 
increased IMT compared with control subjects (Manzi & Wasko, 2000; Ramsey-
Goldman & Manzi, 2001; Van Doornum et al., 2002; Vlachoyiannopoulos et al., 
2003).  While such studies have documented modest rates of plaque lesions, 
this trend has not been explored specifically in African American women and 
estimates may be substantially higher in this population.     
In order to examine the role of inflammation in the relationship between 
SLE and subclinical atherosclerosis in African American women with SLE, the 
extent of subclinical carotid atherosclerosis measured as carotid IMT in 41 
SLE cases identified on the east side of Buffalo, New York and 83 individually 
matched controls were measured, and its relationship to inflammation mark-
ers in the blood examined. 
PATIENTS AND METHODS
Study Population
The Breakfast with a Buddy Biomarkers of Lupus Study was a case-control 
investigation of pre-clinical heart disease, inflammation, and traditional car-
diovascular risk factors in the largely African American cohort of women with 
Systemic Lupus Erythematosus (SLE) from the Buffalo Lupus Project.  Forty-
one African American women with SLE were recruited to participate from the 
Buffalo Lupus Project, a survey and registry component of a five year commu-
nity-based participatory research project investigating lupus and other auto-
immune diseases on the east side of Buffalo, NY.  Eighty-three friend controls 
were individually matched to cases on the basis of sex, age (within five years), 
and race.  Cases identified themselves for participation in the Buffalo Lupus 
Project and released their medical records to be validated against the 1997 
American College of Rheumatology revised criteria for the classification of SLE 
(Hochberg, 1997) by an independent rheumatologist.  For the purposes of 
the present study, cases were asked to invite two or more friends to partici-
pate as controls.  The present study desired controls representing the same 
population as cases, and friends may be likely to use the medical system in 
similar ways. Also biases due to social class are usually reduced since the case 
and friend control will be of similar socioeconomic background (Wacholder, 
McLaughlin, Silverman, & Mandel, 1992; Wacholder, Silverman, McLaughlin, & 
Mandel, 1992a, 1992b).  Controls were required to be free of SLE and/or other 
autoimmune diseases and could not be a relative of a case since autoimmune 
diseases often run in families and controls may be unaware of existing dis-
ease.  All eligible women 18 years of age or older were invited to participate 
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in this study, which was approved by the Health Sciences Institutional Review 
Board at the State University of New York at Buffalo.  All participants provided 
their written informed consent.  Of the 63 participants in the Buffalo Lupus 
Project survey, 33 cases participated in the Breakfast with a Buddy Study, 
corresponding to a 52 percent participation rate.  Seven additional cases ex-
pressed interest and participated in the study without having done a survey, 
after learning of the study from other participants or joining the registry but 
not meeting residential inclusion criteria of the Buffalo Lupus Project Survey.  
Of the 124 controls invited to participate in the Breakfast with a Buddy Study, 
99 participated, corresponding to an 80 percent participation rate.  
Variable Measurements
All research was conducted in the Center for Preventive Medicine (CPM) 
at the State University of New York at Buffalo.  Participation in the Break-
fast with a Buddy Biomarkers of Lupus Study consisted of blood collection, 
physical measurements, an interviewer-administered questionnaire, and an 
ultrasound scan of the carotid arteries, all of which took place during the 
same two-hour clinic visit.  All participants received a light breakfast following 
blood collection, a custom-designed gift basket, and culturally appropriate 
heart-health materials developed by the National Heart, Lung and Blood In-
stitute of the National Institutes of Health for use in African American popula-
tions.  Several risk factors were assessed.
Traditional cardiovascular risk factors.  Information was obtained on age, 
race, education level, household income, smoking habits (current and past 
use), family history of CVD (MI, stroke, or sudden death in a first-degree rela-
tive before the age of 60 years), diabetes (previous diagnosis and/or current 
use of oral hypoglycemic agents or insulin) and fasting glucose levels, physical 
activity, and body mass index (calculated from height and weight).  Current 
hypertensive status was determined using an average of three consecutive 
sitting blood pressure readings of SBP > 140 mmHg or higher or DBP > 90 
mmHg or higher.  Total cholesterol, low-density lipoprotein (LDL) cholesterol, 
high-density lipoprotein (HDL) cholesterol, and triglyceride levels were mea-
sured in fasting blood samples using standardized laboratory tests.  Informa-
tion on current use of anti-hypertensive agents and lipid-lowering agents was 
also obtained.
Inflammation Markers.  Levels of tumor necrosis factor alpha (TNF-α), 
interleukin 6 (IL-6), Fibrinogen, and C-reactive protein (CRP) were assessed 
from fasting blood samples.  TNF-α was analyzed using Luminex technology, 
wherein multiplex assay kits measure multiple analytes simultaneously in 
a single reaction well.  The Human Serum Adipokine Panel B LINCOplex Kit 
(Linco Research, Inc.; St. Charles, MO): Panel B was used to measure TNF-α and 
IL-6.  IL-6 was measured by ultra-sensitive ELISA (R&D Systems, Minneapolis, 
MN) and CRP was measured using the BNII nephelometer from Dade Beh-
ring utilizing a particle enhanced immuno-nepholometric assay (Harris et al., 
1999).  Fibrinogen analysis was conducted using the Stago-Compact method 
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with a Claus Assay and Automated Coag Analyzer kit.  Women were included 
regardless of their history of cardiovascular events.  We obtained information 
about previous MI, angina, coronary revascularization, stroke, or other blood 
vessel diseases.  The prevalence of a CVD event was similar between cases and 
controls (13 cases and 10 controls), systematically controlling for history of an 
event potentially impacting multivariate findings.     
Vascular Disease Measurements. Ultrasound technicians were trained 
and certified to scan and read vascular ultrasounds at the Center for Medical 
Ultrasound at Wake Forest University School of Medicine and Wake Forest 
University Baptist Medical Center in Winston-Salem, North Carolina.  B-mode 
ultrasonographic examinations were performed using a Biosound EASOTE 
AU5 duplex scanner (Italy) equipped with a 7.5-10 MHz linear array imaging 
probe/transducer (LA13A, Florence, Italy) on subjects in the supine position.  
Images of near and far wall IMTs were recorded on the right and left internal, 
common, and bifurcation of the carotid arteries according to previously devel-
oped protocols as for carotid vessels in the Buffalo Cardiometabolic Occupa-
tional Police Stress study (BCOPS) (Violanti, 2004).  For each side of the neck, 
ultrasound technicians first identified both the internal and external vessels of 
the carotid artery by Doppler to make sure the internal vessel was the focus.  
They then identified the optimal angle of interrogation at long view, depend-
ing on the transverse view of the artery coming up the neck.  From the first 
angle, the ultrasound technician moved circumferentially around the neck, 
producing images of the vessel from 30 to 45 degrees anterior and posterior 
from the optimal angle of interrogation, scanning from the distal common 
carotid artery to the internal carotid artery at each angle.  
All scans were recorded on super-VHS videotape for offline analysis.  
Measurement of IMT  was performed using an image analysis work station 
consisting of an Intel P4 3.0 GHz computer (PC800FSB), a DT 3152 scientific 
frame grabber, an optical disk drive, a Sony super-VHS video cassette recorder 
with a Sony 18.1” active matrix LCD monitor and DVI input speakers, and the 
ImagePro measuring software (Media Cybernetics, 2007).  To measure the 
average IMT of a segment, digitized B-mode images were displayed on the 
monitor and two lines were electronically drawn, one along the lumen-intima 
interface and one along the media-adventitia interface.  Interfaces were deter-
mined across part or all of a 1-cm segment depending on clarity of the image.  
The computer then generated one measurement for each pixel over this area, 
for a total of approximately 140 measurements.  The average distance in pixels 
was converted to mm using the equation: 1 pixel = 0.109 mm.
In the present study, multiple carotid sites were used to measure IMT.  
This approach consists of measuring IMT in the near and far walls of the three 
main segments of extracranial carotid arteries (common carotid, bifurcation, 
internal carotid) on both sides of the neck.  The mean common carotid artery 
(CCA) IMT was measured in 12 CCA segments approximately 10mm in length: 
the near and far wall, from three interrogation angles, on both the right and 
left side (2 x 3 x 2=12).  The mean value of these 12 mean CCA IMT values is 
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the MMCCA.  In the rare event (2-3%) one of the segments was not adequately 
visualized, the mean of all the visualized segments was used.  The maximum 
IMT was measured in the CCA, bulb and internal carotid artery (ICA) from 
three interrogation angles on the right and left side.  After selection of the 
single maximum IMT from the three angles of the near and far wall in each 
anatomical segment (1 x 2 x 3=6 on the right and the left), the mean values of 
these 12 single maximum IMT values were computed as the MMXIMT (Bying-
ton et al., 1997; The ACAPS Group, 1992).
 Statistical Analysis 
All analyses were conducted using the SPSS 15.0 computer program 
(SPSS Inc., 2007).  Descriptive data were expressed as mean + standard 
deviation for continuous variables and percentage of cases and controls for 
categorical variables.  To define the relationship between lupus and cardiovas-
cular risk factors, independent samples t-tests were used to assess differences 
in mean values of continuous variables and chi square analysis conducted to 
determine the statistical significance of independence of categorical explana-
tory variables from SLE disease status.  The bivariate relationships between 
IMT and each cardiovascular risk factor and the bivariate relationship between 
SLE and IMT were assessed in separate simple linear regression models.  Tradi-
tional cardiovascular risk factors that reached statistical significance based on 
a bivariate relation with IMT of p < 0.25 and were also significantly correlated 
with inflammation were added to linear models with SLE and selected inflam-
mation marker(s), one at a time.  This was done to assess their individual ef-
fects on each other and their individual/combined effects on the relationship 
between SLE and inflammation.  For multivariate linear regression analyses, all 
variables with a bivariate relation with IMT of p<0.25 were evaluated for inclu-
sion into statistical models to ensure that important variables from a biologi-
cal standpoint were not excluded.  
RESULTS
Table 1 compares traditional cardiovascular, inflammatory, and SLE-
specific variables between SLE cases and controls.  All SLE cases and controls 
were African American females.  The mean age of the entire sample was 49.5 
+ 13.3 (mean + SD) years.  Annual household income was similar between 
groups, while education level was different between cases and controls 
(p=0.07).  Compared with cases, more controls reported not completing high 
school (13.2% of controls compared with 6.7% of cases), while more controls 
reported graduating from college (38.2% of controls compared with 16.7% of 
cases). 
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Table 1: Comparison of traditional cardiovascular, inflammatory, and 
SLE-specific variables in SLE cases and controls
Cases Controls
 Explanatory Variable (n = 41) (n = 83) P
Age, years 50.8 + 11.2 49.6 + 14.7 0.70
Annual household income, % 0.69
Under $10,000 26.7 11.8
$10-29,999 36.6 40.8
$30-49,999 16.7 19.7
Over $50,000 16.7 23.7
Level of education, % 0.07
< 12 years 6.7 13.2
High school graduate or GED 76.7 48.7
College graduate or more 16.7 38.2
Hypertension (SBP > 140 mmHg, DBP > 90 mmHg, or 
self-report and medication use), %
66.7 36.8 0.01
Total cholesterol, mg/dL 189.7 + 36.5 192.3 + 28.5 0.70
LDL cholesterol, mg/dL 115.8 + 31.0 123.7 + 25.5 0.18
HDL cholesterol, mg/dL 56.2 + 22.0 51.1 + 13.2 0.15
Triglycerides, mg/dL 88.6 + 38.2 86.9 + 64.2 0.90
Lipid lowering medication use, % 20.0 14.5 0.56
Antimalarial use, % 46.7 1.3 <0.01
Steroid use, % 33.3 9.2 0.01
Family history of cardiovascular disease, % 33.3 16.0 0.06
Smoking status, Never compared with Past/Current 0.03
Never, % 40.0 65.3
Past smoker, %
Current smoker, %
50.0
10.0
21.4
13.3
BMI (kg/m2) 31.12 + 7.5 31.23 + 6.2 0.94
Physical activity, Inactivity compared with any activity 0.37
None, % 16.7 7.9
Once in a while, % 26.7 34.2
At least 3 times per week, % 56.7 57.9
Mean max IMT, mm 0.87 + 0.18 0.84 + 0.18 0.64
Mean CCA IMT, mm 0.68 + 0.12 0.67 + 0.13 0.87
C-reactive protein, ug/ml 4.1 + 3.6 3.4 + 3.9 0.43
Tumor necrosis factor-alpha, pg/ml 6.3 + 2.8 5.1 + 2.4 0.03
Interleukin-6, pg/ml 4.0 + 3.4 3.2 + 2.8 0.17
Fibrinogen, mg/dL 357.2 + 64.0 365.7 + 61.7 0.54
Except where otherwise indicated, values are the mean + standard deviation.  P-values derived from independent samples 
t-tests for equality of means for continuous measures and chi-square calculations for independence of categorical variables 
(equal variances assumed). SBP-Systolic blood pressure, DBP-Diastolic blood pressure, IMT-intima media thickness, LDL-Low 
density lipoprotein, HDL-High density lipoprotein
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There were no statistically significant differences between SLE cases and 
controls with respect to total cholesterol, and triglycerides.  However, controls 
displayed higher levels of LDL-cholesterol than cases, and cases displayed 
higher levels of HDL-cholesterol than controls (p=0.18 and p=0.15 respec-
tively).  More cases than controls reported lipid lowering medication use (20.0 
percent compared with 14.5 percent) (p=0.56).  Additionally, significantly 
more cases compared with controls used steroids and antimalarials (p=0.01 
and p<0.01 respectively).  High blood pressure, defined by both SBP/DBP 
measurements and blood pressure lowering medication use, was significantly 
more prevalent in cases compared with controls (p=0.01).  Cases also reported 
family history of premature cardiovascular disease more often than controls 
(p=0.06).  The distribution of SLE cases and controls according to smoking sta-
tus was significantly different (p=0.03).  More cases were past or current smok-
ers than controls (60 percent compared with 35 percent).  Although average 
BMI was not significantly different across SLE cases and controls (p=0.94), 
more cases than controls were of normal weight (BMI=18.5-24.9 kg/m2) 
(21 percent compared with 13 percent) and more controls than cases were 
obese (BMI > 30 kg/m2) (49 percent compared with 41 percent).  There was 
no difference in overall physical activity (p=0.37) between cases and controls.  
However, more controls than cases reported engaging in physical activity 
once in a while and at least three times per week (92 percent compared with 
84 percent), while more cases than controls reported not engaging in physical 
activity at all (17 percent compared with 8 percent).  While levels of CRP and 
Fibrinogen were not different across cases and controls (p=0.43 and p=0.54 
respectively), levels of TNF-alpha and IL-6 were higher in cases compared to 
controls (p=0.03 and p=0.17 respectively).  In both cases and controls, distri-
butions of IMT (both mean max and mean CCA) were skewed toward high 
values.  Cases displayed a mean of 0.87 (+ 0.18) mm for mean max IMT and a 
mean of 0.68 (+ 0.12) mm for mean CCA IMT.  Controls were almost identical 
with a mean of 0.84 (+ 0.18) mm for mean max IMT (p=0.64) and a mean of 
0.67 (+ 0.13) mm for mean CCA IMT (p=0.87).
Variables independently associated (p<0.05) with increased mean max 
IMT, using linear regression, included hypertension, past or current smoking, 
TNF-α, and lower BMI (Table 2).  Although not statistically significant, there 
was a 0.10 mm increase in mean max IMT observed in SLE cases compared 
with controls (p=0.33), and a 0.02 mm increase in mean CCA IMT observed in 
SLE cases compared with controls (p=0.87).  BMI displayed an inverse relation-
ship with carotid IMT.  There was a reduction of 0.29 mm in mean max IMT and 
a 0.19 mm reduction in mean CCA IMT per kg/m2 of BMI.  
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Table 2: Variables associated with increased intima-media wall thickness in 
124 SLE cases and controls
Mean max IMT 
(mm)
Mean CCA IMT 
(mm)
Explanatory variable Parameter 
estimate
Parameter 
estimate
P-value
Hypertension (SBP > 
140 mmHg or DBP > 90 
mmHg or self-report and 
medication use)
0.01, 0.08 0.01, 0.08 0.01, 0.08
Smoking status (Never 
and Past/Current Smoker)
0.03, 0.31 0.03, 0.31 0.03, 0.31
BMI (per kg/m2) <0.01,0.05 <0.01,0.05 <0.01,0.05
TNF-α (pg/ml) 0.05, 0.17 0.05, 0.17 0.05, 0.17
           Table 3 shows that after controlling for TNF-alpha, BMI, and hyper-
tension, SLE disease status remained unrelated to mean max IMT and declined 
further in significance with adjustment for other covariates (p=0.33 to p=0.81 
after adjustment for TNF-alpha, BMI, and hypertension).  However, when only 
adjusted for TNF-alpha, the relationship between SLE and mean max IMT 
diminished in strength from a 0.10 mm increase in mean max IMT in SLE cases 
compared with controls to a 0.04 mm increase in mean max IMT for SLE cases, 
suggesting that levels of TNF-alpha partially explain the relationship between 
SLE and mean max IMT.  When BMI was added to the model, the relationship 
between TNF-alpha and mean max IMT diminished in strength from a 0.18 
mm increase  to a 0.16 mm increase in mean max IMT per pg/ml increase in 
TNF-alpha, and TNF-alpha declined further in significance (p=0.08 to p=0.10).  
This trend continued with the addition of hypertension to the model, which 
resulted in the relationship between TNF-alpha and mean max IMT diminish-
ing even more in strength to only a 0.09 mm increase in mean max IMT per 
pg/ml increase in TNF-alpha and losing more significance (p=0.35).  When 
BMI was added to multivariate models with hypertension status, its relation-
ship with mean max IMT became more protective, moving from a 0.29 mm 
reduction to a 0.35 mm reduction in mean max IMT per kg/m2 increase in 
BMI.  Similarly, when hypertension was added to multivariate models with 
BMI, its relationship with mean max IMT increased, from a 0.26 mm increase 
to a 0.32 mm increase in mean max IMT for hypertensive subjects compared 
with normotensive participants, and it gained significance (p=0.01 to p<0.01).  
This trend suggests that BMI and hypertension are more important correlates 
of mean max IMT in this population than are SLE or TNF-alpha.
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Table 3. Variables associated with increased mean max IMT in 124 SLE cases 
and controls, using multivariate linear regression
Adjusted    
parameter (p)
Independent Vari-
able
Crude pa-
rameter (p)
1 2 3
SLE status
(case/control)
0.10 (0.33) 0.04(0.53) 0.05 (0.60)  -.02 (0.82)
TNF-alpha (pg/ml) 0.19 (0.05) 0.18 (0.08) 0.16 (0.10) 0.09 (0.35)
BMI (kg/m2) -.29 (<.01) -.28 (<.01) -.35 (<.01)
Hypertension (yes/
no)
0.26 (0.01) 0.32 (<.01)
1-adjusted for TNF-alpha 
2-adjusted for TNF-alpha and BMI  
3-adjusted for TNF-alpha, BMI, and Hypertension  
Sample previously matched on age
DISCUSSION
In this study, we sought to determine the role of inflammatory bio-
markers in the increased risk of heart disease in SLE, with a focus on African 
American  women who are at highest risk for both conditions.  In doing so, 
both traditional cardiovascular risk factors and more novel inflammatory 
parameters were investigated in a sample of African American women with 
(cases) and without (controls) SLE.  We found that SLE cases and controls were 
very similar with respect to risk factor levels, but differed in the traditional 
CVD risk factor variables of hypertension, family history of CVD, and smoking 
status.  Previous studies have observed cardiovascular risk profile similarities 
between SLE cases and controls (Bruce et al., 2003; Chung et al., 2006; Manzi 
et al., 1997; Petri et al., 1992), suggesting that the 10-year risk of a CHD-related 
event would be the same in SLE cases and controls and that other factors are 
contributing to the documented increased CVD rate in SLE.  The most surpris-
ing finding of the current study was that we did not find a statistically signifi-
cant association between SLE and carotid IMT, especially when the existing 
literature consistently suggests that the development of atherosclerosis is 
accelerated in SLE.  The mean values of carotid IMT for SLE cases and controls 
in the present study were not significantly different from each other [mean 
max IMT (cases)=0.86 mm, mean max IMT (controls)=0.84 mm, p=0.64 and 
mean CCA (cases)=0.68 mm, mean CCA IMT (controls)=0.67 mm, p=0.87].   A 
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0.03 mm difference in mean max IMT observed between cases and controls 
has clinical significance, however.  Population data shows that a 0.03 mm 
difference in IMT is equivalent to three years of vascular age and a difference 
of 0.04 mm separates stroke patients from those without stroke (Burke et al., 
1995).  A significant number of cases compared with controls reported use 
of antimalarials and steroids since that is the usual regimen for secondary 
prevention of SLE, which may explain the slight increase in IMT observed in 
cases compared with controls (Bruce et al., 2003).  Other studies have linked 
increased dosage and duration of use of Prednisone to carotid abnormalities 
(Doria et al., 2003; Manzi et al., 1999), although in the present study neither 
steroid nor antimalarial use were associated with carotid IMT.  In general, our 
study population (both SLE cases and controls) displayed higher IMT values 
than have been observed in previous studies (Doria et al., 2003; Selzer et al., 
2004; van der Meer et al., 2002).  In these studies, conducted in predominantly 
White populations, the average IMT values (both mean max and common 
carotid) of both cases and controls range between 0.50-0.70 mm (Doria et 
al., 2003; Manzi et al., 1999; Selzer et al., 2004; van der Meer et al., 2002).  The 
Atherosclerosis Risk in Communities (ARIC) study was a prospective investiga-
tion of cardiovascular risk factors and outcomes in sub-samples across the 
country.  In investigations of IMT, study samples were between 25 and 37 
percent African American and African American men and women displayed 
higher IMT than White participants.  For example, Burke and associates (1995) 
observed average IMT of 0.73 mm in normotensive African American women 
(Ranjit et al., 2006).  High IMT values observed in the current study may reflect 
the fact that Western New York has one of the highest rates of CHD in the 
US (National Center for Chronic Disease Prevention and Health Promotion; 
Centers for Disease Control and Prevention; Office for Social Environment and 
Health Research, 2000).  Thus, in a population already demonstrating a high 
propensity for CHD, IMT measurement may not be too discriminatory. 
Since no statistically significant associations were observed between 
SLE and carotid IMT (both mean max and mean CCA) in the analytic sample, 
conclusions could not be drawn regarding the role of inflammation in the 
pathway between SLE and carotid IMT with any confidence.  However, within 
the limits of sample size, inflammation appears to at least partially explain the 
relationship between SLE and carotid IMT.  A study with a larger sample size 
would be necessary to better understand the relationship between SLE and 
IMT when selected inflammation markers were introduced to statistical mod-
els.  Additionally, the current study demonstrated that levels of proinflamma-
tory cytokines (limited to levels of TNF-alpha and IL-6) were significantly in-
creased in SLE cases compared with controls (p<0.01).  Additionally, TNF-alpha 
was related to both mean max and mean CCA IMT, although these relation-
ships were diminished or disappeared after adjustment for BMI and hyperten-
sion.  These findings were consistent with previous study findings that have 
linked TNF-alpha to functional changes of the endothelium and hypertension 
(Manabe, Okura, Watanabe, & Higaki, 2005; Sebestjen, Zegura, Videcnik, & Ke-
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ber, 2005).  The observed relationships of TNF-alpha with carotid IMT, as well 
as with BMI, in a predominantly African American sample with high values of 
IMT and BMI, may indicate that TNF-alpha is an important factor to consider in 
future investigations of cardiovascular risk in African Americans.
We found that BMI and hypertension were more important correlates of 
carotid IMT (both mean max and mean CCA) than SLE and the investigated 
inflammation markers.  When added to multivariate models, relationships 
between SLE disease status and IMT didn’t change much, but the observed 
changes (although non-significant), indicate that hypertension may be in the 
pathway.  Such findings are in agreement with other literature in both the 
general population and SLE-specific groups that have also demonstrated the 
importance of high blood pressure in the development of heart disease (Da-
vis, Dawson, Riley, & Lauer, 2001; Doria et al., 2003; Iglseder, Cip, Malaimare, 
Ladurner, & Paulweber, 2005; Paul et al., 2005; Selzer et al., 2004).  However, 
the observed negative relationship between BMI and IMT was contradictory, 
since most studies have observed an increase in cardiovascular risk as BMI 
increases (Diehr, Newman, Jackson, Kuller, & Powe, 2002; Ranjit et al., 2006).  In 
the current study, BMI was negatively correlated to TNF-alpha in both SLE cas-
es and controls, and TNF-alpha in turn was positively associated with carotid 
IMT, which may explain BMI appearing protective if heavier participants had 
lower levels of a factor (TNF-alpha) that corresponded with increased carotid 
IMT.  There is also the possibility that the observed effects, or lack thereof, 
were a function of a BMI threshold.  Approximately 83 percent of the study 
sample fell within overweight or obese BMI categories, making it possible that 
the observed trends are specific to obese African American women.
Findings may have been a function of the homogeneity of the current 
study population with regard to race, since the current study population 
shares gender and age characteristics of previous study samples (Manzi et al., 
1999), which have generally been middle-aged or older and predominantly 
if not completely female.  Since African Americans overall have higher risk of 
cardiovascular disease and are more likely to have characteristics that pro-
mote the atherosclerotic process (high blood pressure, dyslipidemia, smok-
ing, physical inactivity, obesity, diabetes) compared with other racial ethnic 
groups (Adeniyi et al., 2002; Adeyemo et al., 2005; Alderman, Cohen, & Madha-
van, 2000; Crespo, Smit, Andersen, Carter-Pokras, & Ainsworth, 2000; Finkel-
stein, Khavjou, Mobley, Haney, & Will, 2004; Freedman et al., 2005; Ranjit et al., 
2006), this trend may have masked any disease-specific trends in the current 
study that are apparent in other less diverse study populations.  Although 
not statistically significant, the apparent increase in carotid IMT in SLE cases 
compared with controls may have been due to differences between the two 
groups with respect to medication use.  Significantly more SLE cases than con-
trols reported steroid use, and other researchers have found that increased 
prednisone dosage and duration of use were associated with carotid plaque 
in women with SLE (Cooper et al., 2002; Doria et al., 2003; Manzi et al., 1999).
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Strengths and Limitations
Our results must be interpreted cautiously since the study sample was 
small and highly select.  The most compromising shortcoming of the current 
study was small sample size (N=124).  Such a small sample increases the risk 
of Type I error, or inability to detect statistically significant differences that 
may in fact have been present.  This is particularly true in the case of multivari-
ate analyses, wherein effective analytical sample size was further reduced for 
each level of analysis.  Small sample size may have also contributed to an in-
crease in the likelihood of Type II error, and negative or aberrant associations 
observed may in fact be false.    
Overall, participants were highly educated and of higher socioeconomic 
status than middle-aged African American women in the general population.  
Additionally, cases may have appeared healthier than controls with respect to 
traditional cardiovascular risk factors due to increased medical surveillance.  
An additional limitation of the current study is that the SLE cases included 
were not incident cases of the disease, which could affect their risk for CVD 
(i.e., risk factors, lifestyle habits, etc.) and other comorbid disorders.  Other 
studies have observed that cardiovascular risk is associated with disease 
duration (Alarcon et al., 2005; Cooper et al., 2002), suggesting that our group 
of participants with SLE were inherently at increased risk for CVD compared 
with controls, regardless of other factors.  However, SLE is a disease that often 
goes misdiagnosed or undiagnosed in patients for many years (Calvo-Alen 
et al., 2005; Office of Minority Health, 2004; Rus & Hochberg, 2002), making it 
difficult to truly classify cases as incident.  
Another limitation of the present study was reliance on a previous diag-
nosis of SLE to confirm SLE case status and self-report of SLE control status.  
The current study grew out of a community-based participatory research proj-
ect.  Therefore, the study design and implementation incorporated communi-
ty-based participatory research methods to recruit participants and develop 
goodwill in the community with available resources.  While we reviewed their 
medical charts, there was not a clinician on-site to assess symptoms of cases 
and perform laboratory analyses to confirm a diagnosis of lupus.  Due to 
financial constraints, the extent of disease (organ systems involved), its sever-
ity and impact (measured as damage accrual), and activity (assessed with 
high-sensitivity CRP levels, urinalysis, and complete blood cell count) were 
not defined and more novel markers of inflammation such as MMP-9 were not 
investigated.  Patients were not examined to determine the presence of rash, 
mucosal lesions, or other markers of active disease, although self-reported ar-
thritis (both rheumatoid and osteoarthritis) was assessed.  However, medical 
records containing a positive diagnosis of lupus from at least one rheumatolo-
gist were obtained for all 30 cases included in analysis.  Since it is usual clinical 
practice to ascertain a diagnosis of lupus using current American College of 
Rheumatology (ACR) criteria, it is assumed that these criteria were used to 
diagnose cases in the current study.  The Connective Tissue Disease Screening 
Questionnaire (CSQ) was used in cases to further validate self-reported lupus 
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diagnoses and previous clinical diagnoses reflected in medical records.  CSQ 
review, performed by Brigham and Women’s Hospital, revealed that 94 per-
cent of cases in the present study had probable SLE.  The CSQ, however, was 
not used to screen out controls who may have a connective tissue disease.  
Thus, there is a possibility that some degree of misclassification occurred, 
which may partially explain some of the unexpected results found.  However, 
questionnaire responses available from both cases and controls regarding 
other comorbid disorders, including asthma, COPD, Emphysema, cancer, and 
arthritis (both rheumatoid and osteo), revealed that no controls reported 
previously being diagnosed with lupus, COPD, Emphysema or rheumatoid 
arthritis, which increases certainty that controls are indeed controls free of 
these inflammatory mediated conditions.  There is also a reasonable level 
of confidence in self-reported disease status since SLE is a hard diagnosis 
to ascertain for cases, who identified themselves in order to join the Buffalo 
Lupus Project registry and participate in corresponding support activities for 
lupus patients.  Additionally, SLE is a serious enough condition to confidently 
assume that controls should remember experiencing it or being told they had 
it.  Also, studies relying solely on the CSQ to identify controls may not be able 
to identify participants with mild or atypical SLE. 
In addition to strengths of individual matching and a cost-efficient study 
design, the present study was the first of its kind to examine the relationship 
between SLE and carotid IMT in the context of inflammation, in an African 
American sample.
CONCLUSION
Although this study was not able to conclude that SLE was related to 
carotid IMT, it did demonstrate the importance of TNF-alpha, BMI, and hy-
pertension as correlates of both mean max and mean CCA IMT in an African 
American study population.  The clinical consequences of the increased risk of 
atherosclerosis in SLE could be considerable.  Other studies have documented 
modest rates of plaque lesions, but this trend has not been explored specifi-
cally in African American women and estimates may be substantially higher in 
this population.  As other complications and disease manifestations associ-
ated with lupus are better controlled with current therapeutic modalities, 
the relative importance of atherosclerotic disease may increase further.  The 
implication that African Americans share a certain level of CVD risk, regardless 
of SLE disease status, makes it possible that the cardiovascular risk profile of 
African American women with SLE may be different from other racial/ethnic 
groups.    Clinicians providing care for African American patients with SLE 
and other diseases characterized by chronic systemic inflammation should 
be aware of the propensity to atherosclerosis that these patients share.  More 
meticulous screening for cardiovascular risk factors (both traditional and non-
traditional) and more aggressive management of the identified risk factors 
may need to be considered for African American SLE patients.  
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There is a need for larger studies focusing on African American women 
with SLE to determine if the same or different factors are associated with CVD 
risk in this group.  This study’s role may primarily be to act as a sentinel that 
more research is needed to make sure that the most relevant factors are the 
focus of disease prevention on the primary and secondary level in this high-
risk population.      
This work was supported by the following grants from the National 
Institute of Environmental Health Sciences: R01 ES11368 and 3 R01 ES011368-
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